Substantial headway has been made against prostate cancer in the last 15-plus years, thanks in no small part to the UCLA Prostate Cancer Program, which has contributed to the development of effective new drugs for treating advanced forms of the disease; developed better imaging techniques for detecting it; and engendered a better understanding of risk, enabling many patients to avoid unnecessary treatment.
View Complete Newsletter >
Dec 06, 2019
Dr. Robert Reiter -- Healio/HemOnc Today and The Cancer Letter reported on UCLA’s Prostate SPORE designation, which was given to the prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center, UCLA Urology and UCLA Health by the National Cancer Institute. The award comes with an $8.7 million grant to help improve prostate cancer diagnosis and treatment.
Nov 08, 2019
Dr. Robert Reiter -- FOX-TV (San Diego) and other news outlets published a newswire story about an $8.7 million grant given to the UCLA Jonsson Comprehensive Cancer Center by the National Cancer Institute to improve prostate cancer diagnosis and treatment.
